High-Cost Drug Formulary Stewardship: Health System Evaluation of Intravenous Immunoglobulin (IVIG) Utilization

Authors

Christine J. Hurteau PharmD, Yale New Haven Health/Bridgeport Hospital
Christopher Flores PharmD, PCSCP, Yale New Haven Health/Bridgeport Hospital
Rebecca Pulk PharmD, MS, BSP, Yale New Haven Health/Bridgeport Hospital

Document Type

Conference Proceeding

Abstract

• Intravenous immunoglobulin (IVIG) therapy is essential for treating various immune mediated conditions
• Dosing and duration of IVIG varies based on indication, and there is lack of consensus for some indications on ideal dosing strategy
• IVIG is a high cost medication that is being used at higher rates in a five hospital health system compared to similarly sized institutions
• Given the high utilization rates, evaluation of IVIG prescribing patterns and clinical appropriateness was

Publication Date

2024

Comments

Presented at the American Society of Health System Pharmacists (ASHP). Midyear Posters (2024)

Recommended Citation

Hurteau, Christine J. PharmD; Flores, Christopher PharmD, PCSCP; and Pulk, Rebecca PharmD, MS, BSP, "High-Cost Drug Formulary Stewardship: Health System Evaluation of Intravenous Immunoglobulin (IVIG) Utilization" (2024). Posters. 22.
https://scholar.bridgeporthospital.org/poster_presentations/22